Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Thoracic Cancer
|
September 7, 2023
Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as a biomarker in locally advanced unresectable thymic epithelial neoplasm: A single-center, retrospective, longitudinal cohort study
Dong Hyun Kim, Yoojoo Lim, Sukjun Kim, et al.
Histopathology
|
March 13, 2024
An artificial intelligence-powered PD-L1 combined positive score (CPS) analyser in urothelial carcinoma alleviating interobserver and intersite variability
Kyu Sang Lee, Euno Choi, Soo Ick Cho, et al.
NPJ Precision Oncology
|
November 21, 2023
Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes for prediction of prognosis in resected colon cancer
Yoojoo Lim, Songji Choi, Hyeon Jeong Oh, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
November 13, 2025
Pathologist-Artificial Intelligence Concordance in HER2 Interpretation for Advanced Biliary Tract Cancer: Intraobserver, Interobserver, and Human-Artificial Intelligence Variability
Hyunchul Kim, Jinhyung Heo, Soo Ick Cho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 9, 2014
Genomic Alterations in the RB Pathway Indicate Prognostic Outcomes of Early-Stage Lung Adenocarcinoma
Seongmin Choi, Hyeong Ryul Kim, Chang Ohk Sung, et al.
Hepatology (Baltimore, Md.)
|
May 7, 2014
Genomic portrait of resectable hepatocellular carcinomas: implications of RB1 and FGF19 aberrations for patient stratification
Sung-Min Ahn, Se Jin Jang, Ju Hyun Shim, et al.
Journal for Immunotherapy of Cancer
|
February 14, 2024
Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types
Jeanne Shen, Yoon-La Choi, Taebum Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 8, 2024
A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma
Chang Gon Kim, Min Hee Hong, Dahee Kim, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Thoracic Cancer
|
September 7, 2023
Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as a biomarker in locally advanced unresectable thymic epithelial neoplasm: A single-center, retrospective, longitudinal cohort study
Dong Hyun Kim, Yoojoo Lim, Sukjun Kim, et al.
Histopathology
|
March 13, 2024
An artificial intelligence-powered PD-L1 combined positive score (CPS) analyser in urothelial carcinoma alleviating interobserver and intersite variability
Kyu Sang Lee, Euno Choi, Soo Ick Cho, et al.
NPJ Precision Oncology
|
November 21, 2023
Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes for prediction of prognosis in resected colon cancer
Yoojoo Lim, Songji Choi, Hyeon Jeong Oh, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
November 13, 2025
Pathologist-Artificial Intelligence Concordance in HER2 Interpretation for Advanced Biliary Tract Cancer: Intraobserver, Interobserver, and Human-Artificial Intelligence Variability
Hyunchul Kim, Jinhyung Heo, Soo Ick Cho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 9, 2014
Genomic Alterations in the RB Pathway Indicate Prognostic Outcomes of Early-Stage Lung Adenocarcinoma
Seongmin Choi, Hyeong Ryul Kim, Chang Ohk Sung, et al.
Hepatology (Baltimore, Md.)
|
May 7, 2014
Genomic portrait of resectable hepatocellular carcinomas: implications of RB1 and FGF19 aberrations for patient stratification
Sung-Min Ahn, Se Jin Jang, Ju Hyun Shim, et al.
Journal for Immunotherapy of Cancer
|
February 14, 2024
Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types
Jeanne Shen, Yoon-La Choi, Taebum Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 8, 2024
A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma
Chang Gon Kim, Min Hee Hong, Dahee Kim, et al.
Page
of 2